- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +27 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Refractory Acute Leukemia of Ambiguous Lineage
Explore clinical trials studying Refractory Acute Leukemia of Ambiguous Lineage. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
Refractory Acute Leukemia of Ambiguous Lineage trial results
NCT02551718
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, Not Recruiting
A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
NCT05761171
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +21 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center Downey, California, United States
- Loma Linda University Medical Center Loma Linda, California, United States
Active, Not Recruiting
Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
NCT04898894
- Conditions
- Acute Leukemia of Ambiguous Lineage in Relapse, Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, +14 more
- Locations
-
- Rady Children's Hospital-San Diego San Diego, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Childrens Hospital of Philadelphia Philadelphia, Pennsylvania, United States